Effect of intensive lifestyle intervention on C-reactive protein in subjects with impaired glucose tolerance and obesity. Results from a randomized controlled trial with 5-year follow-up

Biomarkers

Volumn 13, Issue 7-8, 2008, Pages 671-679

  Andersson, Jonas ^a   Boman, Kurt ^a   Jansson, Jan Håkan ^a   Nilsson, Torbjörn K ^b   Lindahl, Bernt ^c  

^a Skelleftea County Hospital   (Sweden)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^c UMEÅ UNIVERSITY   (Sweden)

Author keywords

C reactive protein; Exercise; Health behaviour; Insulin resistance; Obesity; Weight loss

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; EXERCISE; FEMALE; FOLLOW UP; HEALTH BEHAVIOR; HIGH RISK POPULATION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OBESITY; PRIMARY MEDICAL CARE; RANDOMIZED CONTROLLED TRIAL; STRESS MANAGEMENT; WEIGHT REDUCTION;

ADULT; BODY MASS INDEX; C-REACTIVE PROTEIN; DIET, REDUCING; EXERCISE; FEMALE; FOLLOW-UP STUDIES; GLUCOSE INTOLERANCE; HEALTH BEHAVIOR; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; OBESITY; STRESS, PHYSIOLOGICAL;

EID: 58049202246     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.1080/13547500802661266     Document Type: Article

References (23)

1. Andersen, L., Dinesen, B., Jorgensen, P., Poulsen, F. and Roder, M. (1993) Enzyme immunoassay for intact human insulin in serum or plasma. Clinical Chemistry, 39, pp. 578-582.
2. Bassuk, S., Rifai, N. and Ridker, P. (2004) High-sensitivity C-reactive protein: Clinical importance. Current Problems in Cardiology, 29, pp. 439-493.
3. DeFronzo, R. and Ferrannini, M. (1991) Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care, 14, pp. 173-194.
4. Esposito, K., Pontillo, A., Palo, CD, Giugliano, G., Masella, M., Marfella, R. and Giugliano, D. (2003) Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: A randomized trial. JAMA, 289, pp. 1799-1804.
5. Frohlich, M., Imhof, A., Berg, G., Hutchinson, WL, Pepys, MB, Boeing, H., Muche, R., Brenner, H. and Koenig, H. (2000) Association between C-reactive protein and features of the metabolic syndrome. Diabetes Care, 23, pp. 1835-1839.
6. Galani, C. and Schneider, H. (2007) Prevention and treatment of obesity with lifestyle interventions: Review and meta-analysis. International Journal of Public Health, 52, pp. 348-359.
7. Kasapis, C. and Thompson, P. (2005) The effects of physical activity on serum C-reactive protein and inflammatory markers: A systematic review. Journal of the American College Cardiology, 45, pp. 1563-1569.
8. Khera, A., McGuire, D., Murphy, S., Stanek, HG, Das, SR, Vongpatanasin, W., Wians, FH, Grundy, SM and de Lemos, JA (2005) Race and gender differences in C-reactive protein levels. Journal of the American College Cardiology, 46, pp. 464-469.
9. Lakka, T., Lakka, H., Rankinen, T., Leon, AS, Rao, DC, Skinner, JS, Wilmore, JH and Bouchard, C. (2005) Effect of exercise training on plasma levels of C-reactive protein in healthy adults: The HERITAGE Family Study. European Heart Journal, 26, pp. 2018-2025.
10. Lindahl, B., Nilsson, TK, Jansson, JH, Asplund, K. and Hallmans, G. (1999) Improved fibrinolysis by intense lifestyle intervention. A randomized trial in subjects with impaired glucose tolerance. Journal of Internal Medicine, 246, pp. 105-112.
11. Marlatt, G. and Gordon, J. (1985) Relapse Prevention, p. 1985. The Guilford Press, New York
12. McLaughlin, T., Abbasi, F., Lamendola, C., Liang, L., Reaven, G., Schaaf, P. and Reaven, P. (2002) Differentiation between obesity and insulin resistance in the association with C-reactive protein. Circulation, 106, pp. 2908-2912.
13. Milani, R., Lavie, C. and Mehra, M. (2004) Reduction in C-reactive protein through cardiac rehabilitation and exercise training. Journal of the American College of Cardiology, 43, pp. 1056-1061.
14. Nicklas, BJ, Ambrosius, W., Messier, SP, Miller, GD, Penninx, BWJH, Loeser, RF, Palla, S., Bleecker, E. and Pahor, M. (2004) Diet-induced weight loss, exercise, and chronic inflammation in older, obese adults: a randomized controlled clinical trial. American Journal of Clinical Nutrition, 79, pp. 554-551.
15. Pearson, T., Mensah, G., Alexander, R., Anderson, JL, Cannon, RO, Criqui, M., Fadl, YY, Fortman, SP, Hong, Y. Myers, GL et al. (2003) Markers of inflammation and cardiovascular disease: Application to clinical and public health practice. A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation, 107, pp. 499-511.
16. Pradhan, A., Manson, J., Rifai, N., Buring, J. and Ridker, P. (2001) C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA, 286, pp. 327-334.
17. Reaven, G. (1988) Banting lecture 1988. Role of insulin resistance in human disease. Diabetes, 37, pp. 1596-1607.
18. Ross, R. (1999) Atherosclerosis - an inflammatory disease. New England Journal of Medicine, 340, pp. 115-126.
19. Tchernof, A., Nolan, A., Sites, C., Ades, P. and Poehlman, E. (2002) Weight loss reduced C-reactive protein levels in obese postmenopausal woman. Circulation, 105, pp. 564-569.
20. Visser, M., Bouter, L., McQuillan, G., Wener, M. and Harris, T. (1999) Elevated C-reactive protein levels in overweight and obese adults. JAMA, 282, pp. 2131-2135.
21. Weinehall, L. (1997) Partnership for health. On the role of primary health care in a community intervention programme.
22. WHO (1985) Expert committee on diabetes mellitus. Technical Report Series 727, Geneva
23. Yudkin, J., Stehouwer, C., Emeis, J. and Coppack, S. (1999) C-reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction. Arteriosclerosis, Thrombosis. and Vascular Biology, 19, pp. 972-978.